Access to a COVID-19 Vaccine and Prevention of Counterfeiting in Indonesian and International Health Law: A comparative Approach

被引:2
|
作者
Haiti, Diana [1 ]
机构
[1] Univ Lambung Mangkurat, Study Program Law, Banjarmasin, Indonesia
来源
关键词
COVID-19; vaccine; prevention of counterfeiting COVID-19 vaccine; International health law; Indonesian health laws; Intellectual property rights; dianahaiti@ulm; ac; id;
D O I
10.5281/zenodo.4756210
中图分类号
DF [法律]; D9 [法律];
学科分类号
0301 ;
摘要
International forums have discussed the need for the original/genuine COVID-19 vaccine to cure and protect the populace from the deadly virus and the issue of its counterfeiting. The International Criminal Police Organization issued global alerts to the law enforcement agencies of its 194 member nations to be aware of Covid-19 vaccine counterfeits. Consequently, the present study's focus has been on the international laws associated with the fundamental rights of individuals to have equitable access to the COVID-19 vaccine worldwide. It has also addressed the international laws used to combat COVID-19 vaccine counterfeits. In addition to the objectives mentioned above, the current study examined the case of Indonesia as a low- and middle-income nation to assess the presence of laws governing the rights of citizens to access COVID-19 vaccination and their protection from counterfeits. The researchers utilized a normative judicial research methodology based on secondary data extracted from available literature and legal documents to accomplish this. Globally, diverse organizations and agencies have stepped forward to secure the rights of individuals to have access to the COVID-19 vaccine without discrimination and to safeguard against counterfeits, according to the findings. Similarly, the results revealed the laws in Indonesia that address infectious diseases and provide citizens with health care protection. The current study is an important addition to the existing body of literature because it not only presents international laws for the prevention of COVID-19 vaccine counterfeiting but also discusses the case of a developing country as a starting point for future researchers.
引用
收藏
页码:148 / 164
页数:17
相关论文
共 50 条
  • [41] Will access to COVID-19 vaccine in Aotearoa be equitable for priority populations?
    Whitehead, Jesse
    Scott, Nina
    Carr, Polly Atatoa
    Lawrenson, Ross
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2021, 134 (1535) : 25 - 34
  • [42] Vaccine access, equity and justice: COVID-19 vaccines and vaccination
    Privor-Dumm, Lois
    Excler, Jean-Louis
    Gilbert, Sarah
    Karim, Salim S. Abdool
    Hotez, Peter J.
    Thompson, Didi
    Kim, Jerome H.
    [J]. BMJ GLOBAL HEALTH, 2023, 8 (06):
  • [43] Ensuring Equitable Access to the COVID-19 Vaccine: The Experience of A Local Health Unit in Rome, Italy
    Turatto, Federica
    Sassano, Michele
    Goletti, Mauro
    Severoni, Santino
    Grossi, Adriano
    Parente, Paolo
    [J]. HEALTHCARE, 2022, 10 (11)
  • [44] COVID-19: An International Public Health Concern
    Ayenigbara, Israel Oluwasegun
    [J]. CENTRAL ASIAN JOURNAL OF GLOBAL HEALTH, 2020, 9 (01):
  • [45] Health Beliefs and Socioeconomic Determinants of COVID-19 Booster Vaccine Acceptance: An Indonesian Cross-Sectional Study
    Wirawan, Gede Benny Setia
    Harjana, Ngakan Putu Anom
    Nugrahani, Nur Wulan
    Januraga, Pande Putu
    [J]. VACCINES, 2022, 10 (05)
  • [46] COVID-19 and opportunities for international cooperation in health
    Buss, Paulo Marchiori
    Tobar, Sebastian
    [J]. CADERNOS DE SAUDE PUBLICA, 2020, 36 (04):
  • [47] Social Economy and covid-19: An international approach
    Alvarez, Juan Fernando
    Bouchard, Marie J.
    Marcuello, Carmen
    [J]. CIRIEC-ESPANA REVISTA DE ECONOMIA PUBLICA SOCIAL Y COOPERATIVA, 2022, 104 : 203 - 231
  • [48] Vaccine politics: Law and inequality in the pandemic response to COVID-19
    Kavanagh, Matthew M. M.
    Singh, Renu
    [J]. GLOBAL POLICY, 2023, 14 (02) : 229 - 246
  • [49] The Arizona Prevention Research Center partnerships in Arizona to promote COVID-19 vaccine health equity
    Nuno, Tomas
    Sierra, Lidia Azurdia
    Wilkinson-Lee, Ada
    Carvajal, Scott
    de Zapien, Jill
    Coulter, Kiera
    Figueroa, Carlos
    Morales, Mario
    Sepulveda, Ramses
    Sepulveda, Refugio
    Ingram, Maia
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [50] The challenges of COVID-19 Delta variant: Prevention and vaccine development
    He, Xuemei
    He, Cai
    Hong, Weiqi
    Zhang, Kang
    Wei, Xiawei
    [J]. MEDCOMM, 2021, 2 (04): : 846 - 854